CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Taro Pharmaceuticals USA Inc. v. Perrigo Israel Pharmaceuticals Ltd.

1:14-cv-00989

Overview

Case Number 1:14-cv-00989
Filing Date 2014-07-28
Status Terminated
Termination Date 2016-05-23
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Perrigo UK FINCO Limited Partnership NPE (University / Research)

Represented By

2 Attorneys Listed

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

David A. Bilson

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200
Fax: +1 (302) 655-4210

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

Perrigo Israel Pharmaceuticals Ltd. Operating Company

Represented By

6 Attorneys Listed

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Steven H. Sklar

Email: ssklar@leydig.com

Kenneth P. Spina

Email: kspina@leydig.com

Jeffrey B. Burgan

Email: jburgan@leydig.com

Bruce M. Gagala

Email: bgagala@leydig.com

David A. Bilson

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200
Fax: +1 (302) 655-4210

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

Plaintiff

Taro Pharmaceuticals North America Inc. Operating Company

Represented By

4 Attorneys Listed

Stephanie Hartmann

Email: shartmann@winston.com

Kevin E. Warner

Email: kwarner@winston.com

Donald H. Mahoney , III

UNDELIVERABLE EMAIL 2/12/2019

Dominick T. Gattuso

Heyman Enerio Gattuso & Hirzel LLP

Tel: +1 (302) 472-7311
Fax: +1 (302) 472-7301

300 Delaware Avenue, Suite 200, Wilmington, DE 19801

Taro Pharmaceuticals USA Inc. Operating Company

Represented By

5 Attorneys Listed

Neema A. Kumar

UNDELIVERABLE EMAIL 2/5/2016

John K. Hsu

Email: jhsu@schiffhardin.com

Christopher Bruno

Email: cbruno@schiffhardin.com

Charles B. Klein

Email: cklein@winston.com

Dominick T. Gattuso

Heyman Enerio Gattuso & Hirzel LLP

Tel: +1 (302) 472-7311
Fax: +1 (302) 472-7301

300 Delaware Avenue, Suite 200, Wilmington, DE 19801

Counter Defendant

Univ. of Tennessee Research Foundation NPE (University / Research)

Represented By

0 Attorneys Listed
No attorneys available

Panda Pharmaceuticals, LLC Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 1 proceeding
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (1 found):
U.S. Courts: 1
U.S. District Court 2015-09-22
1:15-cv-00859

Taro Pharmaceuticals U.S.A., Inc. v. Perrigo UK FINCO Limited Partnership

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8277780
Stable liquid desoximethasone compositions with reduced oxidized impurity
Filed: 2006-05-26
Issued: 2012-10-02
Active (1.4 yrs remaining) +698d PTA
Expires: 2028-04-23
US8715624
Stable liquid desoximethasone compositions with reduced oxidized impurity
Filed: 2012-09-06
Issued: 2014-05-06
Active (5.8 yrs remaining)
Expires: 2032-09-06
US5990100
Composition and method for treatment of psoriasis
Filed: 1998-08-28
Issued: 1999-11-23
Expired (Term Ended)
Expires: 2018-08-28

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+698 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

1

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Procedural / Extension Motion 1

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Plaintiffs' to Answer Defendant's Counterclaims to November 14, 2014 - filed by Taro Pharmaceuticals North America Inc., Taro Pha...
Entry #14 • 2014-10-28 Document →

Docket Entries

(20 total)
Pleading / Complaint

COMPLAINT AND JURY DEMAND filed with Jury Demand against Perrigo Israel Pharmaceuticals Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1561627.) - filed by Taro Pharmaceuticals USA Inc., Taro Pharmaceuticals North America Inc.. (Attachments: # 1 Exhibit A and B, # 2 Civil Cover Sheet)(els) (Entered: 07/29/2014)

Entry #1 • 2014-07-28
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (els) (Entered: 07/29/2014)

Entry #2 • 2014-07-28
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/17/14 and 7/2/14. Date of Expiration of Patent: 9/1/28 and 5/26/26.Thirty Month Stay Deadline: 12/17/2016. (els) (Entered: 07/29/2014)

Entry #3 • 2014-07-28
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,277,780; 8,715,624;. (els) (Entered: 07/29/2014)

Entry #4 • 2014-07-28
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Taro Pharmaceutical Industries Ltd., Other Affiliate Sun Pharmaceutical Industries Ltd. for Taro Pharmaceuticals North America Inc., Taro Pharmaceuticals USA Inc. filed by Taro Pharmaceuticals North America Inc., Taro Pharmaceuticals USA Inc.. (els) (Entered: 07/29/2014)

Entry #5 • 2014-07-28
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc